SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will ...

Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, ...

Tech oligarchs’ wildest visions of tomorrow amount to a modern secular theology that is both mesmerizing and, in his view, ...

Jefferies, BofA Securities, Piper Sandler and Barclays are acting as joint book-running managers for the proposed offering.

Exicure, Inc. ("Exicure" or the "Company") (Nasdaq: XCUR), announced today it received a notice of non-compliance from Nasdaq Stock Market LLC ("Nasdaq") on May 21, 2025 notifying the Company that, as ...

The workplace shouldn’t require you to separate who you are at work from who you are at home. Instead of work-life balance, ...

SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. ("23andMe" or the "Company") (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced its intention to file ...

Dr. Wright brings deep experience across a wide breadth of therapeutic areas and modalities and will guide clinical ...

Gourmey has received an independent validation confirming that its production model is scalable and economically viable.